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Langerhans cells (LCs) are unique antigen-presenting cells (APC) in
the epidermis whose roles in host defense have become clearer over
the last few years.We previously demonstrated that LCs take up protein
antigens and bacterial toxins by extending their dendrites through in-
tact tight junction barriers (Kubo et al., 2009) to initiate protective hu-
moral responses (Nagao et al., 2009; Ouchi et al., 2011). This non-
redundant function for LCs in vivowas observed by controlling the dis-
tribution of antigens andutilizing protein antigens that donot penetrate
epidermal tight junctions and thus are accessible to only LCs (Ouchi et
al., 2011). On the other hand, when epidermal barriers are breached
during epicutaneous Candida albicans infection, LCs are capable ofnd
0B,
nd
C-ND licinducing Th17-mediated cellular responses (Igyártó et al., 2011). The
route of antigen delivery that allows for natural antigen uptake by LCs
was an important factor in determining LC function in these studies.
Langerin is a C-type lectin required for the formation of Birbeck
granules (Kissenpfennig et al., 2005a; Valladeau et al., 2000) and was
demonstrated to be an endocytic receptor in in vitro propagated LCs
and in ﬁbroblasts transfected with Langerin (Valladeau et al., 2000).
However, the genomic ablation of langerin did not result in any obvious
immune phenotypes (Kissenpfennig et al., 2005a), and its function(s) in
vivo had remained elusive. Human LCs have been shown to scavenge
HIV via langerin (de Witte et al., 2007), but functional contributions of
langerin during immune responses have not been demonstrated.
Whether LCs are capable of suppressing immunity has been a topic
of debate. Loss of LCs leads to attenuated disease in leishmaniasis with
decreased numbers of regulatory T (Treg) cells (Kautz-Neu et al.,
2011), and the treatment ofmicewith antigen-conjugated anti-langerin
antibodies results in enhanced Treg cell expansion (Flacher et al., 2014;
Idoyaga et al., 2013). LCs have also recently been shown to induce the
expansion of Treg cells in response to ionizing irradiation (Price et al.,
2015). However, the physiological setting in which LCs mediateense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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speciﬁc manner has yet to be clearly demonstrated.
Past models including contact hypersensitivity responses, intrader-
mal injection of pathogens and transgenic mice expressing neo-
autoantigens have been utilized to explore LC function. However, the
route of antigen delivery or the superphysiological load of antigens
may lead to experimental outcomes that do not reﬂect physiological
LC function. This issue may be avoided by studying immune responses
against keratinocyte-associated autoantigens that are physiologically
expressed.
Desmoglein 3 (Dsg3) is a classic cadherin family cell adhesionmole-
cule and a major desmosomal glycoprotein that is expressed by
keratinocytes (Amagai et al., 1991). Dsg3 is not only critical for main-
taining epidermal integrity, it is also a bona ﬁde autoantigen that is
targeted in pemphigus vulgaris, an autoimmune blistering disease
(Amagai et al., 1991). While mechanisms regarding T cell immunity
against Dsg3 remain incompletely characterized, a mouse model has
helped provide some insight (Takahashi et al., 2009). Experimental au-
toimmune dermatitis (EAD) is amousemodel inwhichCD4+T cells tar-
get Dsg3 to mediate autoimmune skin inﬂammation (Takahashi et al.,
2011) and represents a unique model in which autoimmunity against
a physiologically expressed, functional self-antigen can be studied.
Herein, we utilized in vitro and in vivo systems and determined that
langerin-mediated acquisition of Dsg3 by LCs leads to the expansion of
antigen-speciﬁc Treg cells. We also demonstrate that LCs expanded Treg
cells via a mechanism that involves direct IL-2 signaling in LCs.2. Materials and Methods
2.1. Mice
C57BL/6J and C57BL/6J Rag2−/− mice were purchased from CLEA
Japan, Inc. and the Central Institute for Experimental Animals (Tokyo,
Japan), respectively. Langerin-DTA mice (Kaplan et al., 2005) were
crossed with the C57BL/6J Rag2−/− background. Homozygous or het-
erozygous Langerin-DTR mice (Bennett et al., 2005) in the C57BL/6SJL
(CD45.1) background were obtained by breeding homozygous
Langerin-DTR mice with each other or with C57BL/6SJL wild-type
mice. Dsg3−/− mice were crossed with K5-Dsg1 transgenic mice,
which express another desmosomal protein, Dsg1, in keratinocytes
(Hata et al., 2011). TheDsg1 expression driven by the K5promoter com-
pensates for the loss of Dsg3 and ameliorates the mucosal erosions that
Dsg3−/−mice are prone to develop, thereby enhancing the viability of
Dsg3−/− mice (Hata et al., 2011). For the sake of simplicity, the K5-
Dsg1 transgenic Dsg3−/−mice have been referred to as Dsg3−/−mice
throughout thismanuscript. The Dsg3-speciﬁc T cell receptor transgenic
mice (H1 mice) in the C57BL/6J background were previously generated
(Takahashi et al., 2011). CD25−/− mice were kindly provided by Tai
Xuguang and Alfred Singer (National Cancer Institute, National Insitutes
of Health, Bethesda).
To generate K5-Dsg3-eGFP mice, a transgene vector pGEM3Z-hK5-
mDsg3-EGFP containing the human keratin 5 (K5) promoter [which
was kindly provided by Dr. Junji Takeda (Osaka University)], a full
lengthmouse Dsg3 (mDsg3) and enhanced GFP (eGFP) were construct-
ed. Full length mDsg3 fused with eGFP was subcloned between the β-
globin cassette and BGHpA of the modiﬁed K14pNotIpGEM3Z vector
(Hata et al., 2011). Then, the K14 promoter was replaced with the K5
promoter as previously described (Hata et al., 2011). The nucleotide re-
gion from the K5 promotor to BGHpA was excised and microinjected
into the pronuclei of the C57BL/6J mice zygotes. The zygotes were im-
planted into pseudopregnant foster C57BL/6J mice to generate mDsg3-
eGFP transgenic mice.
Allmicewere bred and housed in speciﬁc pathogen-free facilities. All
animal procedures and study protocols were approved by the Keio Uni-
versity Ethics Committee for Animal Experiments.2.2. Antibodies
Anti-mouse langerin (clone L31, eBioscience) was used either puri-
ﬁed or in conjugated forms labeled in house with Alexa Fluor 647
(Invitrogen). Additional anti-mouse mAbs obtained from BioLegend
(except otherwise noted) were used for ﬂow cytometry or immunoﬂu-
orescence staining: CD122 (TM-β1), CD132 (TUGm2), CD25 (PC61),
CD3ε (145-2C11), CD4 (GK1.5), CD45 (30F-11), CD80 (16-10A1),
CD86 (GL-1), EpCAM (G8.8), Foxp3 (FJK-16s; eBioscience), IL-2 (JES6-
1A12), MHC II (anti-IA/IE; M5/114.15.2), Vβ6 (RR4-7; BD Bioscience),
CD11b (M1/70; eBioscience) and pSTAT5 (pY694: BD Biosciences).
LEAF™ Puriﬁed anti-mouse I-A/I-E (M5/114.15.2, BioLegend) and
the appropriate isotypes were used for functional assays. Mouse CD4
MicroBeads (L3T4, Miltenyi Biotec) were used for CD4+ T cell isolation.
Anti-Cy7 and anti-Biotin MicroBeads were used for the CD11b+ dermal
DC isolation via a MACS cell separation system.
Primary antibodies were detected with Alexa Fluor-labeled second-
ary antibodies (Invitrogen). Cell nuclei were stained with Hoechst
33258 dye (Invitrogen). NAK5 (anti-Dsg3 IgG1 mAb) was used to
stain epidermal sheets.
For in vitro blocking assays, anti-mouse antibodies against I-A/I-E
(M5/114.15.2), CD25 (PC61), CD80 (16-10A1), CD86 (GL-1), CD275
(HK5.3), PD-1 (29F.1A12 and RMP1-14), PD-L1 (10F.9G2), IL-2 (JES6-
1A12), IL-6 (MP5-20F3) and IL-10 (JES5-16E3) from BioLegend, IL-15
(AIO.3) from eBioscience and TGF-beta (1D11) from R&D were used.
2.3. Epidermal Sheet and Cryosection Preparation
Epidermal sheets were prepared as previously described (Nagao et
al., 2009). Brieﬂy, mouse ears were divided into dorsal and ventral
halves with forceps and incubated for 15min at 37 °C on 3.8% ammoni-
um thiocyanate (Wako Pure Chemical Industries) in phosphate buffer
(pH 7.0). The epidermal sheets were manually detached from the der-
mis under a dissecting microscope (Olympus). Tissue samples for cryo-
sections were embedded in O.C.T. compound (Tissue Tek) and frozen at
−80 °C.
2.4. Immunoﬂuorescence Microscopy
Staining of the epidermal sheets and cryosections was performed as
previously described. Brieﬂy, the epidermal sheets or cryosectionswere
ﬁxed in acetone at−20 °C for 15min and were rehydrated in PBS for at
least 5 min (3 times). The samples were blocked with 3% dry milk
(Morinaga) and 5% goat serum (Dako) in PBS for an hour at room tem-
perature. The primary antibodies were incubated overnight at 4 °C and
washed and detected with appropriate secondary antibodies. Nuclei
were stained with Hoechst 33258 (Invitrogen). Image acquisition was
performed with an Axio Observer.Z1 (Zeiss) and the AxioVision soft-
ware (ver. 4.8), with a Leica confocal microscope (TCS-SP5, Leica) or
with a Zeiss confocal microscope (LSM880, Zeiss) and the Zeiss Zen
(v2.1) software. The levels of the images were linearly adjusted using
Photoshop CS5 (Adobe) when necessary. 3D reconstruction images
were built using sp5 software (Leica) and movies were processed
using iMovie (Apple).
2.5. Cell Suspension Preparation
Epidermal cell suspensions were prepared as previously described
with slight modiﬁcations (Nagao et al., 2009). The shaved mouse
trunk skins were ﬂoated on RPMI 1640 medium containing 0.15% tryp-
sin and 0.27mMEDTA at 37 °C for 30 or 45min. The epidermis wasme-
chanically scraped off in 5% FCS-PBS and washed and ﬁltered through
cell strainers (BD Falcon). To obtain the dermal cell suspension, the der-
mis was minced with scissors or scalpels and incubated in RPMI 1640
medium containing 0.25 mg/ml of Liberase TL Research grade (Roche)
and 200 U/ml of DNase I (Sigma) at 37 °C for 60 min. Skin-draining
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excised and disrupted through a cell strainer (BD Falcon) in 5% FCS-PBS
to generate single cell suspensions.2.6. Flow Cytometry
Anti-mouse CD16/32 (clone 93, BioLegend) was routinely used to
block Fcγ receptors. Non-viable cells were excluded with PI (Sigma-Al-
drich), 7AAD (BioLegend) or LIVE/DEAD cell (Invitrogen). Intracellular
staining for Foxp3 (FJK-16s) aswell as for langerin (L31)was performed
after cell surface staining using Foxp3 staining buffer (eBioscience). In-
tracellular staining for langerin was performed because there is no de-
tectable cell-surface staining after trypsinization of epidermal cells
(data not shown). Intracellular staining for pSTAT5 was performed by
ﬁxing cells with BD Phosﬂow™ Fix buffer I (BD Biosciences) followed
by permeabilizing cells with BD Phosﬂow™ Perm Buffer III (BD Biosci-
ences). Data acquisition was performed on a FACS Canto II (BD Biosci-
ences) or LSR II (BD Biosciences) and analyzed using FlowJo (Tree star).2.7. ELISA
For cytokine analysis, cells harvested from epidermis, lymph nodes
and spleens were incubated at a concentration of 2 × 106/ml for 6 h in
complete RPMI 1640 medium supplemented with PMA (5 ng/ml,
Sigma-Aldrich) and ionomycin (500 ng/ml, Sigma-Aldrich). Quantiﬁca-
tion of cytokines in cell culture supernatants was performed using
Mouse IL-17A or IFN-γ ELISAMAX™ Standard Sets (BioLegend) accord-
ing to the manufacturer's instructions.2.8. Preparation of Skin Dendritic Cells
LCs that migrated from skin explants were isolated as previously de-
scribed (Nagao et al., 2009). In short, mouse ears were divided into dor-
sal and ventral halves, cartilage was removed, and the ear halves were
then ﬂoated on 40 ml of complete RPMI 1640 medium supplemented
with Amphotericin B at 37 °C in 10-cm petri dishes. The cells that mi-
grated into the culture medium were collected after 24 h and were
stored at 4 °C. These cells were pooled with cells that were harvested
after an additional 24 h of skin explant incubation in newly replaced cul-
ture medium. EpCAM− CD11b+ dermal DCs were isolated from dermal
cell suspensions using a MACS cell separation system (Miltenyi Biotec).2.9. In vitro T Cell Proliferation Assay
To generate pure and naïve H1 cells, 2 × 106 bonemarrow cells from
Rag2−/− H1 mice were transferred into lethally irradiated (9.5 Gy)
Dsg1-transgenic Dsg3−/−mice. CD4+ T cells were isolated from spleen
and lymph nodes of the bone marrow chimeric mice using a MACS cell
separation system (Miltenyi Biotec). H1 or WT polyclonal CD4+ T cells
(2 × 105 CFSE-labeled) (Life Technologies) were co-cultured with 1 ×
104 LCs in 96-well round-bottom plates. The cells were harvested for
analysis on day 3. For in vitro blocking assays, 10 μg/ml of anti-mouse
monoclonal antibodies were added. 10 ng/ml of recombinant mouse
IL-2 (R&D) in PBS was used for IL-2 treatment experiments.2.10. Experimental Autoimmune Dermatitis
CD4+ T cellswere isolated from spleens and lymphnodes of H1mice
via a MACS cell separation system (Miltenyi Biotec), and 5 × 106
cells were injected intravenously into Rag2−/− and Langerin-DTA
Rag2−/−.2.11. Statistical Analysis
Statistical analyseswere performedwith Student's t-test using Prism
version 5 for MAC OS X (GraphPad Software), and p values ≤0.05 were
regarded as signiﬁcant.
2.12. Nanostring Analysis
Skin-explant LCswere treatedwith 10 ng/ml of rIL-2 for 8 h andRNA
was subsequently extracted. Nanostring analysis was performed ac-
cording to the manufacturer's instructions.
Raw data from the rIL-2 treated skin-explant LCs were uploaded to
nSolver Nanostring software and processed with default quality control
settings. Per sample transcript counts were normalized to the six posi-
tive controls in the nCounter panel and six housekeeping genes (Gusb,
Oaz1, Polr2a, Ppia, Rpl19, Tubb5) and samples were subsequently
partitioned by treatment group (WT orWT+ rIL-2). Ratios for the com-
parison of treatment groups and associated p-values were generated by
the nSolver software.
A heatmap was generated in nSolver using normalized expression
values for the 19 genes that were signiﬁcantly different (p b 0.05) in
both experiments.
A scatterplot for expression data was generated using group expres-
sion values exported from nSolver into Excel, where values were log-
transformed and subsequently plotted in Prism. Genes were chosen
for display out of the 561 total genes analyzed based on their statistical
or biological signiﬁcance.
2.13. Ingenuity Pathway Analysis
Gene expression data from the nCounter Mouse Immunology Panel
were analyzed using Ingenuity Pathway Analysis Version 01-07
(Qiagen). Uploaded ratios from nSolver software were converted to
fold change values in IPA for core analysis and used to calculate a z-
score and p-value corresponding to the prediction of up- or downregu-
lation in Canonical Pathways and Diseases or Functions annotations in
the IPA database. Canonical Pathways with signiﬁcant (p b 0.05) up-
or downregulation in rIL-2-treated LCs were ﬁltered by |z-score| N 1
and assessed for biological relevance. Diseases and Functions were
assessed based on their IPA-predicted activation state (|z-score| N 2).
3. Results
3.1. Langerhans Cells Take Up and Present Desmoglein 3
To determine if LCs take up keratinocyte-associated autoantigens,
we ﬁrst examined epidermal sheets from wild-type mice and stained
them for class IIMHC (MHC II) and Dsg3. The conformation of the extra-
cellular portion of Dsg3 relies on an optimal calcium concentration
(Amagai et al., 1995), which is unlikely to be retained after its internal-
izationwithin LCs. Utilizing an anti-Dsg3mAb that recognizes non-con-
formational epitopes in a calcium-independent manner (Kawasaki et
al., 2006), we detected punctate Dsg3 signals within LCs which were
distinct from signals of cytoplasmic MHC II (Fig. 1A). To conﬁrm that
this observation represented Dsg3 uptake by LCs from keratinocytes,
we generated transgenic mice that expressed a Dsg3-eGFP fusion pro-
tein driven by the keratin 5 promoter (Fig. 1B). Only epidermal
keratinocytes express Dsg3-eGFP in the skin of these mice and the
eGFP signal was detected in epidermal sheets and CD45− MHC II−
keratinocytes via ﬂow cytometry (Fig. 1C,D). Interestingly, we found
that up to 5% of LCs were eGFP+ via ﬂow cytometry analysis of epider-
mal cell suspensions, while eGFP signals were not found in dendritic
epidermal T cells (Fig. 1E,F), indicating that a subset of LCs had taken
up Dsg3-eGFP fusion protein within the epidermis. Similarly, Dsg3+
LCs were detected in WT mice by ﬂow cytometry analysis via anti-
Dsg3 antibody staining (Fig. 1F, right panel). Rare Langerin− CD11b+
Fig. 1. LCs acquire Dsg3 fromkeratinocytes and activate Dsg3-speciﬁc T cells. (A) Dsg3 co-stainedwithMHC II in epidermal sheets. Bar=10 μm. (B) Constructmap for K5-Dsg3-eGFPmice
generation. (C) eGFP visualization in epidermal sheets from K5-Dsg3-eGFP transgenic mice. Bar= 100 μm. (D) eGFP expression in CD45−MHC II− keratinocytes from K5-Dsg3-eGFP and
WTmice via ﬂow cytometry. (E) eGFP detection in CD45+MHC IIhi EpCAM+ LCs and CD45hi CD3εhi MHCII− EpCAM− dendritic epidermal T cells (DETC). (F) Quantiﬁcation of eGFP+ LCs
and DETCs inWT and K5-Dsg3-eGFPmice (left panel) and quantiﬁcation of Dsg3+ LCs and DETCs inWTmice after stainingwith anti-Dsg3 (NAK5) and detection by ﬂow cytometry (right
panel). (G) Detection of eGFP+ CD45+MHC II+ CD11b+ EpCAM− dermal cells from K5-Dsg3-eGFPmice. (H) CFSE-dilution assay for H1Rag cells co-culturedwith LCs in the presence of an
anti-MHC II blocking antibody or an isotype control. As in (H) H1Rag cells co-culturedwith (I) skin-explant LCs fromWT (LCWT) orDsg3−/− (LCDsg3−/−)mice and (J) skin-explant LCWT or
CD11b+ dermal DCs fromWT mice. Data are representative of three independent experiments (n = 3). p values: *b0.05, **b0.01, ****b0.0001.
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demonstrating that LCswere the predominant but not the sole APC sub-
set that had access to keratinocyte-expressed Dsg3-eGFP fusion protein.
3.2. LCs Present Dsg3 in the Context of MHC Class II
To functionally evaluate the immunological consequences of Dsg3
uptake by LCs, we collected LCs from skin explants of unmanipulated
WTmice (LCWT) to beused asAPCs. A subset of themwould be expected
to have taken up Dsg3 from surrounding keratinocytes (Fig. 1A,E,F). To
generate responder T cells, Rag2−/− mice were crossed to TCR (Vβ6)
transgenic mice in which CD4+ T cells express a Dsg3-speciﬁc TCR
(H1 cells) (Takahashi et al., 2011). Bone marrow from these mice was
transferred into lethally irradiated Dsg3−/− mice (Hata et al., 2011).This procedure enabled the development of Dsg3-reactive T cells in a
Dsg3-deﬁcient environment and resulted in high ratios of naïve, Vβ6-
expressing H1 cells (hereafter referred to as H1Rag cells) in the recipient
mice (data not shown) (Takahashi et al., 2011).
When LCWT were co-cultured with carboxyﬂuorescein succinimidyl
ester (CFSE)-labeled H1Rag cells, H1Rag cells underwent robust prolifera-
tion, which was completely blocked by antibodies against MHC II
(Fig. 1H). LCs collected from the skin explants of Dsg3−/− mice
(LCDsg3−/−) failed to activate H1 cells (Fig. 1I), indicating that H1Rag
cell proliferation occurred in a Dsg3-speciﬁc manner. These data dem-
onstrated that the LCs acquired Dsg3 from surrounding keratinocytes
and presented it in the context of MHC II to H1Rag cells. In contrast to
LCs, EpCAM− CD11b+ dermal DCs did not activate H1Rag cells (Fig. 1J).
This can be explained by the small number of dermal DCs that had
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inant APC that took up and presented Dsg3.
3.3. Langerin Is Required for the Uptake of Dsg3
Langerin binds carbohydrate residues (Valladeau et al., 2000). We
hypothesized that the uptake of Dsg3 by LCs, a highly glycosylated pro-
tein, may be mediated by langerin. When we co-stained langerin and
Dsg3 in epidermal sheets prepared from WT mice, we observed that
the punctate Dsg3 signal in LC cytoplasm co-localized with langerin
(Fig. 2A, Supplementary Movie 1). Based on the predominantly cyto-
plasmic localization of MHC II, these LCs exhibited an immature pheno-
type (data not shown). To explore the role of langerin in immune
responses, we utilized mice in which the extracellular domain of the
langerin gene is replaced by the simian diphtheria toxin receptor
(DTR) (Langerin-DTR mice) (Bennett et al., 2005). Mice homozygous
for the langerin-DTR allele (LangerinDTR/DTR) lack functional langerin. In-
deed, staining of epidermal sheets from LangerinDTR/DTRmice forMHC II
and langerin revealed that LCs existed in a normal distribution within
the epidermis but displayed an absence of langerin expression
(Fig. 2B). Apart from their lack of langerin, LCs (LCDTR/DTR) from
LangerinDTR/DTR mice were phenotypically indistinguishable from LCWT
with regard to MHC II, CD80 and CD86 expression (data not shown).
We utilized skin-explant LCWT and LCDTR/DTR as APCs in an in vitro
proliferation assay with CFSE-labeled H1Rag cells as responder T cells.
We also phenotypically evaluated H1 cells that had proliferated intoFig. 2. Langerin is required forDsg3uptake. (A) Confocalmicroscopyof epidermal sheets co-stain
of the outlined area in the upper panels. Bars= 20 μm (upper) and 10 μm (lower). (B) Immuno
co-stained with anti-MHC II and anti-langerin mAbs. (C) CFSE-labeled H1 cells co-cultured with
LangerinDTR/WT (LCDTR/WT) mice. (D) Y-axis, percent divided, represents the frequency of cells a
values: ****b0.0001.Treg and effector T cells (Teff cells). LCWT induced the proliferation of
both T cell subsets (Fig. 2C). Notably, Treg cells were generated despite
the absence of Rag2, a condition that does not favor Treg cell generation
(Szymczak-Workman et al., 2009).
In contrast to LCWT, LCDTR/DTR were markedly impaired in their abil-
ity to activate H1Rag Treg and Teff cells (Fig. 2C,D), indicating that langerin
mediated Dsg3 uptake prior to antigen presentation. LCs that were het-
erozygous for the langerin-DTR allele, LCDTR/WT, were modestly im-
paired in activating H1Rag cells (Fig. 2D), likely reﬂecting decreased
Dsg3 acquisition and presentation of fewer Dsg3 peptide-MHC II com-
plexes to T cells. These results demonstrated a critical role for langerin
during the acquisition of a keratinocyte-derived autoantigen.
3.4. LCs Are Required for Treg Cell Expansion In Vivo
Because skin-explant LCWT expanded both Treg and Teff H1Rag cells in
vitro (Fig. 2C),we sought to conﬁrm the role of LCs in EAD, a CD4+T cell-
mediated autoimmune response against Dsg3 (Takahashi et al., 2011).
In this model, when H1 cells are adoptively transferred into Rag2−/−
mice, they readily inﬁltrate the skin and elicit IFN-γ-dependent re-
sponses directed against keratinocytes (which express Dsg3), causing
apoptosis and obscuring the dermo-epidermal junction (Takahashi et
al., 2011).
We crossed Langerin-DTA (diphtheria toxin fragment A) mice
(Kaplan et al., 2005), which constitutively lack LCs, to the Rag2−/− back-
ground and adoptively transferred CD4+ T cells that were collectededwith anti-Dsg3 (NAK5) and anti-langerinmAbs. Lower panels showhighmagniﬁcation
ﬂuorescencemicroscopy of epidermal sheets from LangerinDTR/WT or LangerinDTR/DTR mice
skin-explant LCs fromWT (LCWT), Dsg3−/− (LCDsg3−/−), LangerinDTR/DTR (LCDTR/DTR) or
mong the original input population of CD4+ Vβ5+ T cells that have undergone division. p
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cells in the Rag2-sufﬁcient background facilitates Treg cell analysis
(Szymczak-Workman et al., 2009). EAD developed in Langerin-DTA
Rag2−/−mice (Fig. 3A), consistentwith a previous demonstration of au-
toimmune T cell activation in the absence of DCs (Teichmann et al.,
2010). Interestingly, Langerin-DTA Rag2−/− mice exhibited an
aggravated skin phenotype with signiﬁcantly elevated clinical scores
(Fig. 3A). Histological analysis revealed a more prominent interface
dermatitis in Langerin-DTA Rag2−/− mice that was accompanied by
an increased number of CD4+ Vβ6+ (Dsg3-speciﬁc) cells in the
epidermis (Fig. 3B,C).
Re-stimulation of CD4+ T cells from lesional epidermis in vitro re-
vealed an increased production of IL-17 as well as a trend toward in-
creased IFN-γ (Fig. 3D). Flow cytometry analysis of the skin-draining
lymph nodes revealed a decreased expansion of Treg cells in mice that
lacked LCs (Fig. 3E). In aggregate, although LCs activated both Teff and
Treg H1 cells in vitro, the lack of LCs led to impaired expansion of Treg
cells and exacerbated inﬂammation in vivo, highlighting their role in
suppressing autoimmunity.
3.5. LCs Preferentially Expand Polyclonal Treg Cells
Human LCs are capable of expanding polyclonal Treg cells in vitro in
the absence of exogenous antigens or stimulation (Seneschal et al.,
2012). To explore the mechanism by which skin explant LCs expand
Treg cells, we utilized CSFE-labeled syngeneic WT CD4+ T cells as re-
sponder cells rather than H1Rag cells because the activation of Teff cells
and cytokines that they produce may have secondary effects on Treg
cell expansion.
Consistent with the human setting, a signiﬁcant portion of Treg cells,
but not Teff cells, underwent proliferation (Fig. 4A), demonstrating that
LCs preferentially expanded Treg cells in the absence of autoimmune TFig. 3. The loss of LCs leads to exacerbated autoimmunity. H1 T cells were adoptively transferre
scores of EAD inmice that have (Rag2−/−) or lack (Langerin-DTA Rag2−/−) LCs. p=0.0215. (B)H
EAD in indicated mice. (C) Quantiﬁcation of CD45+ CD3+ CD4+ Vβ6+ cells in the epidermis via
suspensionswere analyzed for IFN-γ or IL-17 concentration via ELISA. (E) Quantiﬁcation of Vβ6+
values: *b0.05, **b0.01.cells. The Treg cells that proliferated in this experiment may be speciﬁc
for various epidermal self-antigens that were acquired by LCs.
LCs in epidermal cell suspension as well as those from skin explants
expressed a variety of molecules that play major roles in immune regu-
lation, including MHC II, CD80, CD86 and PD-L1 (data not shown) as
well as cytokines IL-6, 10, 15, and TGF-β1 (Fig. 4B).We added neutraliz-
ing antibodies against these and other molecules that are involved Treg
cell induction (Busse et al., 2012; Fontenot et al., 2005), and found
that only anti-MHC II and anti-IL-2 antibodies had notable effects on
Treg cell expansion, with modest effects of IL-6 blockage (Fig. 4C,D,E).
Blockage of IL-2 receptor alpha (CD25) had a similar effect than IL-2
neutralization (Fig. 4F).
The importance of TGF-β1 for induced Treg cells is well-established
(Li and Rudensky, 2016). The observation that a blocking antibody
against TGF-β1 had no effect on LC-mediated Treg cell expansion
(Fig. 4E) was consistent with the down-regulation of Tgfb1 expression
by skin-explant LCs, as comparedwith LCs sorted from freshly prepared
epidermal cell suspensions (Fig. 4B). Furthermore, thymus-derived Treg
cell markers Helios and Neuropilin-1 were expressed by LC-expanded
Treg cells (Fig. 4G). These data suggested that LCsmediate the expansion
of naturally-occurring Treg cells, rather than the expansion of induced
Treg cells. Thus, LCs expand Treg cells that are likely to be naturally-
occuring, via a mechanism that involves the IL-2-IL-2 receptor axis.
3.6. IL-2 Receptor Signaling in LCs
The effect of IL-2 and CD25 blockage on Treg cells could be explained
by direct effects on T cells. Interestingly, upon emigration skin-explant
LCs highly upregulated CD25 (IL2Rα), consistent with previous reports
(Larsen et al., 1990; Steiner et al., 1986), and to a lesser extent IL-2Rβ
and IL-2Rγ chains (Fig. 5A), suggesting that IL-2 might directly affect
LCs.d into Rag2−/−mice to generate EAD. (A) Phenotype (3 weeks post transfer) and clinical
&E (upper panels) and frozen sections stained for CD4 (lowerpanels) from lesional skin of
ﬂow cytometry. (D) Supernatants of in vitro stimulated (PMA/ionomycin) epidermal cell
Treg cells in skin-draining lymph nodes and spleen in indicatedmice via ﬂow cytometry. p
Fig. 4. LCs induce the expansion of polyclonal Treg cells (A) CFSE-dilution assay utilizing polyclonal CD4+ T cells that were isolated from syngeneicWTmice, co-culturedwith skin-explant
WT LCs. Dot plots show the gating strategy for CD4+ T cells after co-culture. Histograms show FoxP3+ or FoxP3− CD4+ T cells. (B) Real-time PCR analysis for indicated cytokine mRNA
expressed by skin-explant LCs (Explant LCs), LCs (Fresh LCs), keratinocytes and dendritic epidermal T cells (DETCs) that were FACS sorted from freshly prepared epidermal cell
suspensions. (C - F) CFSE-dilution assay as in (A) with antibodies or isotypes added to the co-culture as indicated. The Y-axis, percent divided, represents the frequency of CD4+
FoxP3+ T cells among original input population that have undergone division. (G) Flow cytometry analysis for cell-surface markers on Treg cells expanded by LCs in vitro, stained with
antibodies against indicated molecules (red) or isotypes (gray). p values: *b0.05, **b0.01, ****b0.0001.
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phosphorylation (pSTAT5) upon engagement of IL-2 with the IL-2 re-
ceptor complex (O'Shea and Plenge, 2012). We therefore stained for
pSTAT5 and detected it in LCs from both the epidermis and lymph
nodes of WT mice. Furthermore, pSTAT5 levels were decreased in LCs
from CD25−/−mice (Fig. 5B), indicating that IL-2 signaling takes place
in LCs.
To further characterize the effect of IL-2 on LCs, skin-explant LCs ob-
tained from WT mice (Fig. S1A,B) were exposed to recombinant IL-2
(rIL-2) in vitro for 8 h. RNAwas extracted and transcripts for 561 immu-
nology-related genes were quantiﬁed via Nanostring analysis. rIL-2 in-
duced gene expression changes in LCs (Fig. 5C). Highly signiﬁcant
changes included decreased expression of Ciita, a regulator of MHC II,
and increased Tgfb1 and Smad3 expression (Fig. 5D), both of which are
associated with TGF-β signaling and LC migration (Mohammed et al.,
2016). There was a trend for upregulated Il2rg expression aswell as sta-
tistically signiﬁcant upregulation of Il2rb in response to rIL-2 (Fig. 5C,D).
To predict the biological signiﬁcance of rIL-2-induced overall gene
expression changes in LCs, we performed Ingenuity Pathways Analysis.
Whereas themitogen-activated protein kinases (MAPK) signaling path-
way has been reported to be activated in response to ultraviolet irradi-
ation in LCs (Wang et al., 2011), rIL-2 exposed LCs exhibited
downregulation of these pathways (Fig. 5E). Among upregulatedpathways were those that related to cell motility and migration, as
well as PI3K/AKT and p14/p19ARF pathways, both of which have been
demonstrated to be required for LC homeostasis (Kellersch and
Brocker, 2013; Sparber et al., 2014). Signiﬁcant decreases in disease-as-
sociated pathways that reﬂect the activation of APCswere also detected
(Table S1). Taken together, rIL-2 has effects on biological pathways that
are known to be relevant in LC physiology, suggesting that IL-2 signaling
in LCs evokes a less activated but motile phenotype that may represent
homeostatic migration of LCs that carry autoantigens (Hemmi et al.,
2001) and is consistent with a previous study reporting IL-2-mediated
increased DC motility in rats (Kradin et al., 1996).
In contrast to human in vitro-derived DCs that produce IL-2 to acti-
vate T cells (Wuest et al., 2011), LCs did not express Il2 (Fig. 4B). We
therefore hypothesized that LCs may acquire IL-2 from Teff cells, a
major source of IL-2. Indeed, immunoﬂuorescence analysis of cytospin
preparation of LCs and syngeneicWTCD4+T cells thatwere co-cultured
for 4 days revealed that LCs were in close proximity to IL-2+ FoxP3− T
cells, and that LCs had acquired IL-2 protein on their cell surfaces (Fig.
S2A). Similarly, IL-2-bearing LCs were observed near IL-2+ cells in the
T cell zone in skin draining lymph nodes (Fig. S2B). These data sug-
gested that LCs acquire IL-2 from IL-2-producing T cells nearby. Given
that dendritic epidermal T cells express Il2 (Fig. 4B) and that pSTAT5
is decreased in epidermal LCs of CD25−/− mice (Fig. 5B), dendritic
Fig. 5. IL-2 signaling occurs in LCs and is required for optimal LC-mediated Treg cell expansion (A) Expression of the IL-2 receptor complex by LCs from indicated sources. (B) Flow
cytometry analysis for pSTAT5 in LCs from freshly prepared epidermal cell suspensions or lymph nodes from WT or CD25−/−mice. (C) Grouped expression values for rIL-2-treated
skin explant LCs (WT + rIL-2) were plotted against vehicle-treated LCs (WT + vehicle) for all 561 nCounter Mouse Immunology Panel (Nanostring) genes. (D) Differential gene
expression between rIL-2- and vehicle-treated LCs was signiﬁcant (p b 0.05) for 19 genes in the Nanostring analysis. (E) Canonical IPA pathways with signiﬁcant up- or
downregulation in rIL-2-treated LCs. (F) CFSE-labeled syngeneic WT or CD25−/− CD4+ T cells were co-cultured with WT or CD25−/− LCs. (G) Quantiﬁcation of the percentage of CD4+
FoxP3+ T cells from (F). The Y-axis, percent divided, represents the frequency of CD4+ FoxP3+ T cells among original input population that have undergone division. Data are
representative of 3 independent experiments. p values: *b0.05, **b0.01, ****b0.0001.
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within the epidermis.
3.7. IL-2-Mediated LC Conditioning Is Required for Treg Cell Expansion
Finally, to determine the consequence of impaired IL-2 signaling in
LCs during Treg cell proliferation, we co-cultured WT syngeneic T cellswith skin explant LCWT and LCs from CD25−/− mice (LCCD25−/−) and
found that LCCD25−/− were impaired in their capability to induce the
proliferation of CD25+ FoxP3+ Treg cells (Fig. 5F,G). To eliminate the ef-
fect of CD25 expressed on T cells, we co-cultured LCWT or LCCD25−/−
with CD25−/− CD4+ T cells. This experiment is valid because FoxP3+
Treg cells are able to develop in CD25−/−mice (Fontenot et al., 2005).
Indeed, CD25−/− CD4+ FoxP3+ T cells co-cultured with LCWT
Fig. 6. Triangular cell interaction supports Treg proliferation. Langerhans cells take up
Desmoglein-3 via langerin and display it through MHC-II molecules to induce Treg
proliferation. In addition, IL-2 produced by non-Treg cells is required for both
conditioning of LC function and subsequent Treg cell expansion.
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state in vivo (Willerford et al., 1995). However, consistent with the re-
sults obtained with WT CD4+ Treg cells, co-culture with LCCD25−/− led
to a decreased proliferation of CD25−/− CD4+ FoxP3+ Treg cells (Fig.
5F,G). These data collectively demonstrate that CD25 on LCs was re-
quired for optimal Treg cell expansion and that the IL-2-IL-2 receptor
axis in LCs conditioned them to expand Treg cells.
4. Discussion
Pemphigus vulgaris is an autoantibody-mediated blistering skin dis-
ease, which can be debilitating and potentially life-threatening if not
properly treated (Stanley and Amagai, 2006). Although IgG-mediated
inhibition of Dsg3 function is the major mechanism that leads to the
loss of keratinocyte adhesion and blister formation, autoreactive T
cells participate upstream in the immune response to help B cells to pro-
duce autoantibodies (Takahashi et al., 2009), and further upstream, it is
likely that APCs acquire and present autoantigens to activate
autoreactive T cells. Better understanding of mechanisms by which
APCs take up an epidermal autoantigen such as Dsg3, and better charac-
terization of subsequent immune responseswould provide a foundation
for the development of novel therapeutic strategies against not only
pemphigus vulgaris, but also other autoimmune blistering diseases
that target epidermal antigens, such as bullous pemphigoid, epidermal
bullosa acquisita, and perhaps other T cell-mediated diseases such as li-
chen planus and erythemamultiforme, in which T cells directlymediate
the cell death of keratinocytes (Gru and Salavaggione, 2017). In this
work, we asked whether LCs, given their proximity to keratinocyte-as-
sociated autoantigens, are themajor APC to regulate immune responses
against keratinocyte-expressed Dsg3.
In previous work, functional analyses of LCs had utilized infectious
agents or haptens, and the conclusion of experiments that explored
the tolerogenic aspects of LCs had been somewhat variable (Kaplan et
al., 2008; Kautz-Neu et al., 2010). The nature of antigens, how and
where they are captured, aswell as the location and extent of inﬂamma-
tion may inﬂuence experimental outcomes. The experimental systems
utilized hereinwere unique in thatwe did not utilize any exogenous an-
tigens, neoantigens or adjuvants, whichmay alter the homeostatic func-
tion of LCs. Dsg3 is expressed exclusively by epidermal keratinocytes in
the skin. Owing to this, nomanipulations were required to observe LCs'
immune responses toward the antigen, ensuring that LCs capturedDsg3
in the absence of external cues, and importantly, at physiological doses.
The discovery of langerin reoriented the LC ﬁeld, allowing for the
identiﬁcation of migrated LCs and the generation of in vivo depletion
models (Bennett et al., 2005; Kaplan et al., 2005; Kissenpfennig et al.,
2005b; Valladeau et al., 2000). However, despite its demonstration as
an endocytic receptor in vitro (Valladeau et al., 2000), langerin-deﬁcient
mice failed to exhibit any obvious phenotypes (Kissenpfennig et al.,
2005a). Furthermore, although langerin functions as a scavenging re-
ceptor against HIV (deWitte et al., 2007), its roles in immune responses
had remained incompletely characterized. The co-localization of
langerin with non-conformational Dsg3 epitopes within LCs prompted
us to address the role of langerin during self-antigen uptake. This hy-
pothesis, that the C-type lectin langerin could bind Dsg3, was reason-
able because Dsg3 is highly glycosylated (Amagai et al., 1991).
Because langerin is essential for the formation of Birbeck granules
(Valladeau et al., 2000) and Birbeck granules are reportedly involved
in the routing of antigen for antigen processing (van der Vlist et al.,
2011), more work is needed to unequivocally show that langerin medi-
ates the uptake of, rather than the proper routing of, acquired antigens.
We observed an upregulation of the IL-2 receptor complex on skin-
explant LCs. It has long been known that mature Langerhans cells ex-
press CD25 (IL2Rα) (Larsen et al., 1990; Steiner et al., 1986), however,
the functional role of IL2Rα for LCs has remained largely unknown.
Our data show that IL-2 signaling actually takes place within LCs and
conditions them to optimally induce Treg cell expansion. In vitro-derivedhumanmyeloid DCs produce IL-2. Because blockage of CD25 on DCs im-
paired their ability to activate T cells, it was suggested that DCs present
IL-2 in-trans via CD25 to activate T cells (Wuest et al., 2011). However,
LCs did not express IL-2 mRNA before or after emigration from the skin.
Although it remains to be investigatedwhere this event occurs, gene ex-
pression analyses of LCs and data from in vitro co-culture experiments
suggested that LCs and Treg cells may acquire biologically active IL-2
from nearby non-Treg cells in the epidermis and/or the lymph nodes.
While IL-2 conditions LCs to induce Treg cell expansion, Treg cells also re-
quire the cytokine for proliferation. Furthermore, Treg cells additionally
require antigen presentation by LCs, collectively forming a unique trian-
gular relationship (Fig. 6). IL-2 signaling has not been previously dem-
onstrated to take place in APCs, and it would be of interest to
determine if this phenomenon can be extended to other APC subsets.
Naive Treg cells are thought to circulate until they are activated by
DCs in the lymph node (Li and Rudensky, 2016). Some activated Treg
cells can become memory Treg cells, whose presence has been shown
in both mouse and human skin (Rosenblum et al., 2011; Sanchez
Rodriguez et al., 2014). Treg cells have also been found in human epider-
mis (Seneschal et al., 2012) where they co-localized with LCs. It was
postulated that the direct association of LCs and Treg cells in skin may
be involved in memory responses. It is therefore possible that LCs regu-
late various aspects of the Treg cell life cycle. Although our study in mice
cannot yet be directly translated to human diseases, it is reasonable to
hypothesize that LC-Treg cell interactions are also relevant in various au-
toimmune and inﬂammatory skin diseases, thereby representing an at-
tractive therapeutic target.
In conclusion, we have demonstrated that LCs take up the epidermal
antigenDsg3 via langerin and that direct IL-2-mediated signaling condi-
tions them to optimally induce the expansion of Treg cells. Although LCs
activated both Teff and Treg cells in the autoimmune setting, the loss of
LCs in vivo led to exacerbated skin inﬂammation. Taken together, the
ﬁnding that LCs preferentially induced the expansion of polyclonal Treg
cells suggests that LCs suppress autoimmunity via Treg cell expansion
in the steady state. This observation is consistent with a previous report,
in which epicutaneously administered Dsg3 induced skin inﬂammation
302 D.Y. Kitashima et al. / EBioMedicine 27 (2018) 293–303in MRL-lpr mice, a model of systemic autoimmunity (King et al., 2015).
Further work should be conducted to determine the functional role of
the IL-2 pathway in LCs in vivo and the mechanism by which IL-2-con-
ditioned LCs induce the expansion of Treg cells. Considering previous
studies that have demonstrated LCs' roles in protective immunity
(Igyártó et al., 2011; Ouchi et al., 2011), LCs are likely to be versatile
and context-dependent in their function (Doebel et al., 2017). Exploring
environmental cues that govern LCs' immunological polarity should en-
able new strategies to control skin immunity and to achieve tolerogenic
responses in autoimmune skin diseases.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ebiom.2017.12.022.
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